Furthermore, SLE patients with severe PAH exhibit enhanced expression of various growth factors and chemokines such as RANTES/CCL5 and fractalkine/fractalkine (CX3CL1) within the pulmonary artery, emphasizing the complex interplay of factors involved in this condition. Here, CX3CL1 is linked to pulmonary arterial hypertension.